![Jin Zhong Zhang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jin Zhong Zhang
Amministratore Delegato presso Eluminex Biosciences (Suzhou) Ltd.
Posizioni attive di Jin Zhong Zhang
Società | Posizione | Inizio | Fine |
---|---|---|---|
Eluminex Biosciences (Suzhou) Ltd.
![]() Eluminex Biosciences (Suzhou) Ltd. BiotechnologyHealth Technology Eluminex Biosciences (Suzhou) Ltd. is a privately held biotechnology company located in Suzhou, China. Eluminex Biosciences is committed to developing innovative pharmaceuticals, drug delivery systems, and regenerative tissue for significant unmet vision-threatening or lifestyle limiting ophthalmic diseases in various markets. The Chinese company focuses on ophthalmology and recombinant human collagen technology, with a goal to become a leading healthcare company in developing irreversible loss of optical quality of the cornea due to disease or damage, diabetic macular edema, and wet age-related macular degeneration. The company was founded in 2020 by Jin Zhong Zhang, who has been the CEO since then. | Amministratore Delegato | 01/01/2020 | - |
Presidente | 01/01/2020 | - | |
Fondatore | 01/01/2020 | - |
Storia della carriera di Jin Zhong Zhang
Statistiche
Distribuzione geografica
Cina | 2 |
Posizioni
Chief Executive Officer | 1 |
Chairman | 1 |
Founder | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Eluminex Biosciences (Suzhou) Ltd.
![]() Eluminex Biosciences (Suzhou) Ltd. BiotechnologyHealth Technology Eluminex Biosciences (Suzhou) Ltd. is a privately held biotechnology company located in Suzhou, China. Eluminex Biosciences is committed to developing innovative pharmaceuticals, drug delivery systems, and regenerative tissue for significant unmet vision-threatening or lifestyle limiting ophthalmic diseases in various markets. The Chinese company focuses on ophthalmology and recombinant human collagen technology, with a goal to become a leading healthcare company in developing irreversible loss of optical quality of the cornea due to disease or damage, diabetic macular edema, and wet age-related macular degeneration. The company was founded in 2020 by Jin Zhong Zhang, who has been the CEO since then. | Health Technology |
- Borsa valori
- Insiders
- Jin Zhong Zhang
- Esperienza